- Home
- AXTI vs MNOV Comparison
AXTI vs MNOV Comparison
Compare AXTI & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXTI
- MNOV
- Stock Information
- Founded
- AXTI 1986
- MNOV 2000
- Country
- AXTI United States
- MNOV United States
- Employees
- AXTI N/A
- MNOV N/A
- Industry
- AXTI Semiconductors
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- AXTI Technology
- MNOV Health Care
- Exchange
- AXTI Nasdaq
- MNOV Nasdaq
- Market Cap
- AXTI 93.9M
- MNOV 87.3M
- IPO Year
- AXTI 1998
- MNOV 2005
- Fundamental
- Price
- AXTI $1.97
- MNOV $2.13
- Analyst Decision
- AXTI Strong Buy
- MNOV
- Analyst Count
- AXTI 5
- MNOV 0
- Target Price
- AXTI $5.30
- MNOV N/A
- AVG Volume (30 Days)
- AXTI 462.6K
- MNOV 151.4K
- Earning Date
- AXTI 10-31-2024
- MNOV 11-13-2024
- Dividend Yield
- AXTI N/A
- MNOV N/A
- EPS Growth
- AXTI N/A
- MNOV N/A
- EPS
- AXTI N/A
- MNOV N/A
- Revenue
- AXTI $94,685,000.00
- MNOV N/A
- Revenue This Year
- AXTI $32.13
- MNOV N/A
- Revenue Next Year
- AXTI $12.84
- MNOV N/A
- P/E Ratio
- AXTI N/A
- MNOV N/A
- Revenue Growth
- AXTI 15.24
- MNOV N/A
- 52 Week Low
- AXTI $1.73
- MNOV $1.12
- 52 Week High
- AXTI $5.64
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- AXTI 41.90
- MNOV 62.13
- Support Level
- AXTI $2.00
- MNOV $1.70
- Resistance Level
- AXTI $2.23
- MNOV $2.55
- Average True Range (ATR)
- AXTI 0.11
- MNOV 0.19
- MACD
- AXTI -0.01
- MNOV 0.04
- Stochastic Oscillator
- AXTI 48.00
- MNOV 63.16
About AXTI AXT Inc
AXT Inc is a developer and producer of compound and single-element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.